PMID- 32685788
OWN - NLM
STAT- MEDLINE
DCOM- 20210608
LR  - 20210608
IS  - 2501-2533 (Electronic)
IS  - 2457-4325 (Print)
IS  - 2457-4325 (Linking)
VI  - 64
IP  - 2
DP  - 2020 Apr-Jun
TI  - The role of Visual Evoked Potential (VEP) in monitoring the progression and in 
      guiding the treatment of glaucoma patients with poor compliance.
PG  - 205-212
AB  - Objectives: The objectives of the present study were to analyze the possibility 
      of using pattern VEPs (VEP of pattern type) in glaucoma patients and their role 
      in the follow-up and coordination/ management of anti-glaucoma treatment. 
      Patients and Methods: This is a prospective study on 54 eyes of 30 consecutive 
      glaucoma patients, whose compliance capacity did not allow automatic perimetry 
      and OCT scan to be carried out. The patients were divided into two groups: group 
      A - the study group and group B - the control group. All patients underwent FO 
      exam and pachymetry, plus VEP exam for group A patients. Patients were analyzed 
      at the initial visit and at 1 month, 3, 6, 12 months. Statistical analysis was 
      made using t-test, ANOVA, Fisher test and Pearson correlation coefficient. 
      Results: These participants presented a positive correlation between C/ D ratio 
      and the latency of the P100 wave at 1 degree and a negative correlation between 
      C/ D ratio and the amplitude of the P100 wave both at 1 degree (60 arc minutes) 
      and at 0.25 degrees (15 arc minutes). During the study, the values of the latent 
      P100 changed statistically at 6 months and at 1 year. Using all the data, the 
      authors of the study considered it necessary to modify the treatment for 2 
      patients out of 13 in group B and for 9 patients out of 16 in group A (p = 
      0,02892). Conclusions: VEP supplies additional/ further data that significantly 
      help guiding the treatment and monitoring the progression, therefore, it should 
      be part of the routine examination for these patients. Further studies are 
      necessary to deepen our understanding of the visual evoked potentials utility.
CI  - (c)Romanian Society of Ophthalmology.
FAU - Firan, Anne Marie
AU  - Firan AM
AD  - Barnsley District Hospital, NHS trust, England.
FAU - Iancu, Raluca Claudia
AU  - Iancu RC
AD  - Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
FAU - Bujor, Inna Adriana
AU  - Bujor IA
AD  - Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
FAU - Ciuluvica, Radu Constantin
AU  - Ciuluvica RC
AD  - "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
FAU - Tudosescu, Ruxandra
AU  - Tudosescu R
AD  - Department of Ophthalmology, "Regina Maria" Private Health Care, Bucharest, 
      Romania.
FAU - Ungureanu, Emil
AU  - Ungureanu E
AD  - Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
FAU - Pasca, Irena Gabriela
AU  - Pasca IG
AD  - Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
FAU - Voinea, Liliana
AU  - Voinea L
AD  - Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
FAU - Istrate, Sinziana
AU  - Istrate S
AD  - Department of Ophthalmology, "Regina Maria" Private Health Care, Bucharest, 
      Romania.
LA  - eng
PT  - Journal Article
PL  - Romania
TA  - Rom J Ophthalmol
JT  - Romanian journal of ophthalmology
JID - 101677459
RN  - 0 (Antihypertensive Agents)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Antihypertensive Agents/*therapeutic use
MH  - Disease Progression
MH  - Evoked Potentials, Visual/*physiology
MH  - Female
MH  - Follow-Up Studies
MH  - Glaucoma/drug therapy/*physiopathology
MH  - *Guideline Adherence
MH  - Humans
MH  - Intraocular Pressure/*physiology
MH  - Male
MH  - Middle Aged
MH  - Monitoring, Physiologic/*methods
MH  - *Patient Compliance
MH  - Prospective Studies
PMC - PMC7339685
OTO - NOTNLM
OT  - amplitude
OT  - glaucoma
OT  - latency
OT  - visual evoked potential
EDAT- 2020/07/21 06:00
MHDA- 2021/06/09 06:00
PMCR- 2020/05/01
CRDT- 2020/07/21 06:00
PHST- 2020/07/21 06:00 [entrez]
PHST- 2020/07/21 06:00 [pubmed]
PHST- 2021/06/09 06:00 [medline]
PHST- 2020/05/01 00:00 [pmc-release]
AID - RomJOphthalmol-64-205 [pii]
PST - ppublish
SO  - Rom J Ophthalmol. 2020 Apr-Jun;64(2):205-212.